Tag : NASDAQ Cannabis

Cannabis News Market Watch

Tilray Inc. Files For Proposed IPO on Nasdaq

Editor
Tilray Inc., A Canadian cannabis cultivator, processor, and distributor, has filed a registration statement with the U.S. Securities and Exchange Commission (SEC) for a proposed initial public offering (IPO) on the Nasdaq Global Select Market. The ticker symbol “TLRY” will be used, and will offer shares of its Class 2...
Cannabis News Global Health Hemp News Market Watch

GW Pharmaceuticals Receives Orphan Drug Designation from the European Medicines Agency (EMA)

Editor
On February 27, 2018, GW Pharmaceuticals, PLC (Nasdaq:GWPH) (“GW) announced that the European Medicines Agency (EMA) has granted orphan drug designation for cannabidiol (CBD) for the treatment of tuberous sclerosis (TS). GW has started a Phase 3 clinical trial of Epidiolex® (cannabidiol) as an adjunctive therapy for the treatment of...